| Lindsey Hatcher, | |
|
2 Connecticut St, San Francisco, CA 94107-2451 | |
| (415) 621-5055 | |
| Not Available |
| Full Name | Lindsey Hatcher |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2 Connecticut St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003355330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 292640 (California) | Primary |
| 225X00000X | Occupational Therapist | 15820 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Hatcher, 521 N Claremont St, San Mateo, CA 94401-1707 Ph: (650) 245-0641 | Lindsey Hatcher, 2 Connecticut St, San Francisco, CA 94107-2451 Ph: (415) 621-5055 |
News Archive
VOA News examines an influx of patients suffering from kala azar, also known as visceral leishmaniasis, and malaria in a South Sudan hospital, writing, "The pediatric ward at the main hospital in Bentiu is overcrowded and under-staffed as an unusually high number of children suffering from kala azar and malaria have been brought in for treatment."
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
Onyx Pharmaceuticals, Inc. today announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
A program that focuses on strengthening parenting skills also improves symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) in 3-8 year-olds, according to researchers at the at the University of North Carolina at Chapel Hill. FPG scientists completed a rigorous review of evidence that demonstrated the effectiveness of the "Incredible Years Basic Parent Program."
› Verified 2 days ago
Financial District Sport And Spine Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 632 Commercial St, 4th Floor, San Francisco, CA 94111 Phone: 415-318-8138 | |
Cortland Robert Kim, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3019 Geary Blvd, San Francisco, CA 94118 Phone: 415-387-6564 Fax: 415-387-2013 | |
Shintaro Tatebe, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Parnassus Ave, A-68, San Francisco, CA 94143 Phone: 415-353-8574 | |
Dr. Brianna Joy Vandersloot, DPT, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1200 Gough St, San Francisco, CA 94109 Phone: 415-921-1211 | |
Mr. Matt Sheehy, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1635 Divisadero St Ste 300, San Francisco, CA 94115 Phone: 415-833-4325 | |
Mr. Robin Chung Bor Wong, RPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 818 Jackson St, Suite 201, San Francisco, CA 94133 Phone: 415-421-5678 Fax: 415-421-8231 |